Publications by Dr Gary Beale - ePrints

Browsing publications by Dr Gary Beale.

Newcastle Authors	Title	Year
Dr Marco Zaki Dr Sari Alhasan Dr Ruchi Shukla Misti McCain Maja Laszczewska et al.	Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?	2022
Dr Gary Beale Dr Emma Haagensen Huw Thomas Lan Wang Charlotte Revill et al.	Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo anti-tumour activity in colorectal cancer	2016
Tristan Reuillon Dr Sari Alhasan Dr Gary Beale Annalisa Bertoli Alfie Brennan et al.	Design and synthesis of biphenyl and biphenyl ether inhibitors of sulfatases	2016
Dr Sari Alhasan Dr Beate Haugk Laura Ogle Dr Gary Beale Anna Long et al.	Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma	2016
Duncan Miller Dr Benoit Carbain Dr Gary Beale Dr Sari Alhasan Professor Helen Reeves et al.	Regioselective sulfamoylation at low temperature enables concise syntheses of putative small molecule inhibitors of sulfatases	2015
Dr Sari Alhasan Dr Gary Beale Professor Herbie Newell Professor Helen Reeves	Suppression of SULF2, an extracellular endosulfatase up-regulated in hepatocellular cancers, modulates WNT signalling and inhibits cell growth	2012
Dr Emma Haagensen Suzanne Kyle Dr Gary Beale Dr Ross Maxwell Professor Herbie Newell et al.	The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition	2012
Dr Joseph Gray Dr Dipanker Chattopadhyay Dr Gary Beale Dr Gillian Patman Dr Luca Miele et al.	A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease	2009
Dr Gary Beale Ahmad Alserri Dr Luca Miele Dr Gillian Patman Professor Ann Daly et al.	Claudin 10 (CLDN10) - a Candidate Suceptibility Gene for NAFLD Progression	2009
Dr Gary Beale Laura Pascoe Dr Luca Miele Professor Mark Walker Professor Chris Day et al.	The Kruppel-Like Factor 6 (KLF6) Genotype Which is Associated With NAFLD Progression is Associated with Higher Fasting Serum Glucose Levels in Healthy Individuals	2009
Dr Gary Beale Dr Dipanker Chattopadhyay Dr Joseph Gray Dr Stephen Stewart Dr Mark Hudson et al.	AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease	2008
Dr Luca Miele Dr Gary Beale Dr Gillian Patman Julian Leathart Professor Chris Day et al.	The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease	2008
Dr Gary Beale Dr Luca Miele Professor Helen Reeves Professor Chris Day	Differential expression of GSTT1 and GSTT2 is associated with more advanced fibrosis in patients with NAFLD	2007
Dr Luca Miele Dr Gary Beale Julian Leathart Professor Chris Day Professor Helen Reeves et al.	The KLF6 (IVS1-27G > a) polymorphism is associated with non-progressive NAFLD	2007